BMRN insider transactions
BioMarin Pharmaceutical Inc. (BMRN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for BMRN
- Director Countouriotis Athena was granted 7,490 shares, increasing direct ownership by 55% to 21,040 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Walbert Timothy P was granted 7,490 shares, increasing direct ownership by 77% to 17,270 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Ho Maykin was granted 7,490 shares, increasing direct ownership by 27% to 35,500 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Hombach Robert J. was granted 7,490 shares, increasing direct ownership by 18% to 49,360 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Enyedy Mark J was granted 7,490 shares, increasing direct ownership by 55% to 21,040 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Dere Willard H was granted 7,490 shares, increasing direct ownership by 19% to 46,440 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Clark Ian T was granted 7,490 shares, increasing direct ownership by 107% to 14,490 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Bodem Barbara W. was granted 7,490 shares, increasing direct ownership by 55% to 21,045 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Anderson Elizabeth M was granted 7,490 shares, increasing direct ownership by 22% to 41,940 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Commercial Officer Hubbard Cristin covered exercise/tax liability with 2,318 shares, decreasing direct ownership by 5% to 42,472 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief R&D Officer Friberg Gregory R sold $176,682 worth of shares (3,281 units at $53.85), decreasing direct ownership by 6% to 51,818 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- SEC Form 4 filed by Davis George Eric4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- SEC Form 4 filed by Guyer Charles Greg4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- SEC Form 4 filed by Mueller Brian4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- SEC Form 4 filed by Hardy Alexander4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- SEC Form 4 filed by Hubbard Cristin4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- SEC Form 4 filed by Friberg Gregory R4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Technical Officer Guyer Charles Greg covered exercise/tax liability with 9,109 shares and was granted 14,990 shares, increasing direct ownership by 7% to 85,833 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Legal Officer Davis George Eric covered exercise/tax liability with 7,177 shares and was granted 14,570 shares, increasing direct ownership by 10% to 79,833 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Financial Officer Mueller Brian covered exercise/tax liability with 9,945 shares and was granted 18,740 shares, increasing direct ownership by 8% to 125,431 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Chief Executive Officer Hardy Alexander covered exercise/tax liability with 2,941 shares and was granted 62,440 shares, increasing direct ownership by 37% to 218,887 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Technical Officer Guyer Charles Greg sold $996,744 worth of shares (16,486 units at $60.46), decreasing direct ownership by 17% to 79,953 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Technical Officer Guyer Charles Greg was granted 15,222 shares, increasing direct ownership by 19% to 96,439 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief R&D Officer Friberg Gregory R sold $381,937 worth of shares (6,326 units at $60.38), decreasing direct ownership by 14% to 37,578 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Legal Officer Davis George Eric was granted 15,224 shares and sold $1,599,103 worth of shares (26,061 units at $61.36), decreasing direct ownership by 13% to 72,453 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Financial Officer Mueller Brian was granted 16,482 shares, increasing direct ownership by 16% to 116,638 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Mueller Brian was granted 375 shares, increasing direct ownership by 0.38% to 100,156 units (SEC Form 5)5 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Meier Richard A gifted 500 shares, decreasing direct ownership by 0.39% to 126,926 units (SEC Form 5)5 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Hubbard Cristin was granted 80 shares, increasing direct ownership by 0.26% to 30,625 units (SEC Form 5)5 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Guyer Charles Greg was granted 379 shares, increasing direct ownership by 0.47% to 81,217 units (SEC Form 5)5 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Friberg Gregory R was granted 398 shares, increasing direct ownership by 0.91% to 43,904 units (SEC Form 5)5 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Davis George Eric was granted 375 shares, increasing direct ownership by 0.45% to 83,290 units (SEC Form 5)5 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- VP, Chief Accounting Officer Ramchandani Rashmi Virendra was granted 25,610 shares (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- SEC Form 3 filed by new insider Ramchandani Rashmi Virendra3 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Chief Executive Officer Hardy Alexander was granted 375 shares and covered exercise/tax liability with 16,570 shares, decreasing direct ownership by 9% to 159,388 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief R&D Officer Friberg Gregory R covered exercise/tax liability with 3,304 shares, decreasing direct ownership by 7% to 43,506 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Clark Ian T was granted 7,000 shares (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- SEC Form 3 filed by new insider Clark Ian T3 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Commercial Officer Hubbard Cristin covered exercise/tax liability with 2,155 shares, decreasing direct ownership by 7% to 30,545 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Walbert Timothy P was granted 6,650 shares, increasing direct ownership by 212% to 9,780 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Meier Richard A was granted 6,650 shares, increasing direct ownership by 6% to 127,426 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Hombach Robert J. was granted 6,650 shares, increasing direct ownership by 19% to 41,870 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Ho Maykin was granted 6,650 shares, increasing direct ownership by 31% to 28,010 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Enyedy Mark J was granted 6,650 shares, increasing direct ownership by 96% to 13,550 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Dere Willard H was granted 6,650 shares, increasing direct ownership by 21% to 38,950 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Countouriotis Athena was granted 6,650 shares, increasing direct ownership by 96% to 13,550 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Bodem Barbara W. was granted 6,650 shares, increasing direct ownership by 96% to 13,555 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Director Anderson Elizabeth M was granted 6,650 shares, increasing direct ownership by 24% to 34,450 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- GVP, Chief Accounting Officer Burkhart Erin covered exercise/tax liability with 996 shares and sold $105,928 worth of shares (1,786 units at $59.31), decreasing direct ownership by 16% to 14,173 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Commercial Officer Hubbard Cristin was granted 273 shares and sold $17,723 worth of shares (273 units at $64.92) (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- GVP, Chief Accounting Officer Burkhart Erin sold $92,618 worth of shares (1,295 units at $71.52), decreasing direct ownership by 7% to 16,955 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- GVP, Chief Accounting Officer Burkhart Erin covered exercise/tax liability with 823 shares and was granted 5,970 shares, increasing direct ownership by 39% to 18,252 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Legal Officer Davis George Eric covered exercise/tax liability with 16,249 shares and was granted 12,940 shares, decreasing direct ownership by 4% to 82,915 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Commercial Officer Hubbard Cristin was granted 13,310 shares, increasing direct ownership by 69% to 32,700 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief R&D Officer Friberg Gregory R was granted 17,750 shares, increasing direct ownership by 61% to 46,810 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Technical Officer Guyer Charles Greg was granted 13,310 shares and covered exercise/tax liability with 20,127 shares, decreasing direct ownership by 8% to 80,838 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Financial Officer Mueller Brian covered exercise/tax liability with 18,497 shares and was granted 16,640 shares, decreasing direct ownership by 2% to 99,781 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Chief Executive Officer Hardy Alexander covered exercise/tax liability with 2,933 shares and was granted 44,360 shares, increasing direct ownership by 31% to 175,583 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- EVP, Chief Technical Officer Guyer Charles Greg sold $501,355 worth of shares (7,034 units at $71.28), decreasing direct ownership by 7% to 87,655 units (SEC Form 4)4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
- Amendment: New insider Walbert Timothy P claimed ownership of 416 shares (SEC Form 3)3/A - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)